PL3387898T3 - Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej - Google Patents

Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej

Info

Publication number
PL3387898T3
PL3387898T3 PL18174068T PL18174068T PL3387898T3 PL 3387898 T3 PL3387898 T3 PL 3387898T3 PL 18174068 T PL18174068 T PL 18174068T PL 18174068 T PL18174068 T PL 18174068T PL 3387898 T3 PL3387898 T3 PL 3387898T3
Authority
PL
Poland
Prior art keywords
identification
monitoring
molecular weight
monoclonal immunoglobulins
immunoglobulins based
Prior art date
Application number
PL18174068T
Other languages
English (en)
Inventor
David R. Barnidge
David L. Murray
Original Assignee
Mayo Foundation For Medical Education And Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation For Medical Education And Research filed Critical Mayo Foundation For Medical Education And Research
Publication of PL3387898T3 publication Critical patent/PL3387898T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/02—Details
    • H01J49/10—Ion sources; Ion guns
    • H01J49/16—Ion sources; Ion guns using surface ionisation, e.g. field-, thermionic- or photo-emission
    • H01J49/161—Ion sources; Ion guns using surface ionisation, e.g. field-, thermionic- or photo-emission using photoionisation, e.g. by laser
    • H01J49/164—Laser desorption/ionisation, e.g. matrix-assisted laser desorption/ionisation [MALDI]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Plasma & Fusion (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL18174068T 2013-03-15 2014-03-10 Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej PL3387898T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361792944P 2013-03-15 2013-03-15
PCT/US2014/022475 WO2014150170A1 (en) 2013-03-15 2014-03-10 Identification and monitoring of monoclonal immunoglobulins by molecular mass
EP14770418.3A EP2966985B1 (en) 2013-03-15 2014-03-10 Identification and monitoring of monoclonal immunoglobulins by molecular mass
EP18174068.9A EP3387898B1 (en) 2013-03-15 2014-03-10 Identification and monitoring of monoclonal immunoglobulins by molecular mass

Publications (1)

Publication Number Publication Date
PL3387898T3 true PL3387898T3 (pl) 2020-10-19

Family

ID=51580707

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18174068T PL3387898T3 (pl) 2013-03-15 2014-03-10 Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej

Country Status (7)

Country Link
US (1) US12546782B2 (pl)
EP (3) EP3729958B1 (pl)
DK (2) DK3387898T3 (pl)
ES (3) ES2951899T3 (pl)
PL (1) PL3387898T3 (pl)
PT (1) PT3387898T (pl)
WO (1) WO2014150170A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014150170A1 (en) 2013-03-15 2014-09-25 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins by molecular mass
WO2015131169A2 (en) * 2014-02-28 2015-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
US10267806B2 (en) 2014-04-04 2019-04-23 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
WO2016018978A1 (en) 2014-07-29 2016-02-04 Mayo Foundation For Medical Education And Research Quantifying monoclonal antibody therapeutics by lc-ms/ms
JP6968058B2 (ja) * 2015-09-24 2021-11-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 質量分析法による免疫グロブリン遊離軽鎖の同定
CN109863395B (zh) 2016-09-07 2023-05-23 梅约医学教育与研究基金会 分子量法鉴定和监测裂解免疫球蛋白
GB2567793B (en) 2017-04-13 2023-03-22 Micromass Ltd A method of fragmenting and charge reducing biomolecules
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2019055631A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF ACID HYDROLYSIS PRODUCTS OF IMMUNOGLOBULIN HEAVY CHAINS
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
GB201808529D0 (en) 2018-05-24 2018-07-11 Binding Site Group Ltd Identification of immunoglobulins usong mass spectrometry
US20230042129A1 (en) * 2019-12-11 2023-02-09 Erasmus University Medical Center Rotterdam Method for Monitoring of Deep Remissions in Multiple Myeloma and Other Plasma Cell Dyscrasias
CN115684606B (zh) * 2022-10-21 2023-11-28 南方医科大学珠江医院 一种m蛋白检测的方法
CN117849159B (zh) * 2024-01-09 2025-01-07 融智生物科技（青岛）有限公司 M蛋白的检测方法、电子设备及存储介质

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1075394A (en) * 1912-03-29 1913-10-14 Charles Penruddocke Band Detachable tab for collars.
JPH0449299A (ja) 1990-06-14 1992-02-18 Tosoh Corp 免疫グロブリンフラグメントの精製法
US5567282A (en) * 1994-01-25 1996-10-22 Wang; Hann-Ping On-capillary electrophoretic immunosubtraction for classification and typing of M-proteins
US20030027216A1 (en) * 2001-07-02 2003-02-06 Kiernan Urban A. Analysis of proteins from biological fluids using mass spectrometric immunoassay
US5922184A (en) * 1997-07-21 1999-07-13 Bio-Rad Laboratories, Inc. Computer-directed detection of paraproteins
US5846735A (en) 1996-04-18 1998-12-08 University Of Iowa Research Foundation Hepatitis C virus Fc-binding function
AU2001292312A1 (en) 2000-09-29 2002-04-08 Chugai Seiyaku Kabushiki Kaisha Method of analyzing antibody molecule structure
EP1356121A2 (en) * 2001-02-01 2003-10-29 Ciphergen Biosystems, Inc. Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
AU2002309423B2 (en) 2001-06-06 2007-11-22 Fujirebio Diagnostics Ab Method to measure gene expression ratio of key genes
WO2003046148A2 (en) 2001-11-29 2003-06-05 Thermo Finnigan Llc Polypeptide quantitation
ATE327512T1 (de) * 2001-12-08 2006-06-15 Micromass Ltd Massenspektrometrie-verfahren
AU2002357547A1 (en) * 2001-12-13 2003-06-23 Zeptosens Ag Optically transparent substrate for a maldi measuring system and the use thereof
US20120208295A1 (en) * 2004-01-13 2012-08-16 Wuxi WeiYi Zhinengkeji, Inc. Methods and compositions for mass spectrometry analysis
WO2004085455A1 (en) * 2003-03-24 2004-10-07 The University Of Hong Kong A diagnostic assay for the human virus causing severe acute respiratory syndrome (sars)
CA2522709A1 (en) * 2003-04-17 2004-11-04 Ciphergen Biosystems, Inc. Polypeptides related to natriuretic peptides and methods of their identification and use
US20060177870A1 (en) * 2003-04-28 2006-08-10 Ciphergen Biosystems, Inc Immunoassays
US7709610B2 (en) * 2003-05-08 2010-05-04 Facet Biotech Corporation Therapeutic use of anti-CS1 antibodies
WO2005071421A1 (en) * 2004-01-16 2005-08-04 Ciphergen Biosystems, Inc. Specific detection of troponin and modified forms of troponin
DE102004007005A1 (de) * 2004-02-12 2005-09-08 Bruker Daltonik Gmbh Massenspektrometrische Häufigkeitsbestimmungen von Proteinen
ES2549077T3 (es) 2004-04-07 2015-10-22 Genentech, Inc. Espectrometría de masas de conjugados de anticuerpos
CN101044242B (zh) * 2004-06-10 2013-10-30 维文蒂阿生物技术股份有限公司 肿瘤特异性抗体
KR101319848B1 (ko) * 2004-07-20 2013-10-18 심포젠 에이/에스 재조합 폴리클로날 단백질 또는 폴리클로날 세포주의구조적 특성화 방법
GB0501741D0 (en) * 2005-01-27 2005-03-02 Binding Site The Ltd Antibody
WO2006119435A2 (en) 2005-05-04 2006-11-09 Invitrogen Corporation Identification of cancer biomarkers and phosphorylated proteins
MX2007015416A (es) * 2005-06-08 2008-02-19 Millennium Pharm Inc Metodos para la identificacion, evaluacion y tratamiento de pacientes con terapia contra cancer.
US20110177492A1 (en) 2005-06-16 2011-07-21 3M Innovative Properties Company Method of classifying chemically crosslinked cellular samples using mass spectra
JP2007024631A (ja) 2005-07-14 2007-02-01 Human Science Shinko Zaidan 同位体標識法
TWI338779B (en) 2005-07-21 2011-03-11 Academia Sinica Methods,compositions and systems for assaying at least one target analyte in a sample
CA2619825A1 (en) * 2005-08-19 2007-03-01 Centocor, Inc. Proteolysis resistant antibody preparations
DE102005042100A1 (de) * 2005-09-05 2007-03-08 Sirs-Lab Gmbh Verfahren zur in vitro Diagnose von Sepsis mit Haptoglobin-Related Protein
DE102005042132A1 (de) * 2005-09-05 2007-03-08 Sirs-Lab Gmbh Verfahren zur Diagnose von Sepsis mit IgM
EP1973940A2 (en) * 2006-01-17 2008-10-01 Biolex Therapeutics, Inc. Compositions and methods for humanization and optimization of n-glycans in plants
JP5420396B2 (ja) 2006-04-28 2014-02-19 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 粘膜乾燥状態に関する検討
WO2007130875A2 (en) * 2006-05-02 2007-11-15 Genentech, Inc. Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry
EP2038413A4 (en) 2006-06-28 2010-01-06 Lineagen Inc DEVICES, COMPOSITIONS AND METHODS FOR MONITORING THE PROGRESS OF CHRONIC OBSTRUCTIVE LUNG DISORDERS UNDER QUICK OR SLOW DEGRADING CONDITIONS
KR100862904B1 (ko) * 2006-07-20 2008-10-13 주식회사 서린바이오사이언스 단백질 고정화용 마이크로칩
US9500656B2 (en) * 2006-08-10 2016-11-22 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with cancer therapy
US20090203602A1 (en) * 2006-09-01 2009-08-13 Cohava Gelber Compositions and methods for diagnosis and treatment of type 2 diabetes
US20080317745A1 (en) * 2006-09-15 2008-12-25 Boruchov Adam M Methods of diagnosing, treating, or preventing plasma cell disorders
WO2008057083A1 (en) 2006-11-09 2008-05-15 Wyeth Methods of analyzing glycomolecules
US7462489B2 (en) 2006-11-09 2008-12-09 Ley Klaus F Methods for identifying and analyzing biomarkers from plasma-derived microparticles
ES2374403T3 (es) 2006-12-21 2012-02-16 Novartis Ag Cuantificación de anticuerpos.
GB0704764D0 (en) 2007-03-12 2007-04-18 Electrophoretics Ltd Isobarically labelled reagents and methods of their use
FI20075278A0 (fi) 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet
US8501907B2 (en) 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
KR20150059813A (ko) 2007-08-10 2015-06-02 센토코 오르토 바이오테크 인코포레이티드 질환 표시자로서의 면역글로불린 절단 단편, 및 그의 검출 및 결합을 위한 조성물
NZ584684A (en) * 2007-11-22 2012-10-26 Symphogen As A method for characterization of a recombinant polyclonal protein
US20100261216A1 (en) * 2007-12-21 2010-10-14 Bianca Eser Stability testing of antibodies
CN101354379B (zh) * 2008-01-18 2012-09-19 许洋 用质谱检测多发性骨髓瘤特征蛋白的试剂
WO2009100390A2 (en) 2008-02-08 2009-08-13 Mayo Foundation For Medical Education And Research Classifying amyloidosis
WO2009148528A2 (en) * 2008-05-30 2009-12-10 Millennium Pharmaceuticals, Inc. Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment
WO2010002911A2 (en) * 2008-06-30 2010-01-07 H. Lee Moffitt Cancer Center And Research Institute, Inc. Methods and materials for monitoring myeloma using quantitative mass spetrometry
WO2010085345A1 (en) * 2009-01-22 2010-07-29 Ludwig Institute For Cancer Research Ltd. Methods and compositions for diagnosis and treatment of malignant and non-malignant gammopathies
US20100190652A1 (en) 2009-01-27 2010-07-29 Srinivasa Nagalla Biomarkers for Detection of Neonatal Sepsis in Biological Fluid
SG173589A1 (en) 2009-02-09 2011-09-29 Roche Glycart Ag Immunoglobulin glycosylation pattern analysis
EP2233502A1 (en) 2009-03-27 2010-09-29 Deutsches Rheuma-Forschungszentrum Berlin Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
WO2010119295A1 (en) 2009-04-16 2010-10-21 Cambridge Enterprise Limited Biomarkers
JP5379616B2 (ja) 2009-09-09 2013-12-25 株式会社日立製作所 粥状硬化性動脈硬化のマーカー因子と用途
WO2011072197A2 (en) 2009-12-11 2011-06-16 Purdue Research Foundation Detection of oxidized polypeptides
GB0922240D0 (en) 2009-12-21 2010-02-03 Cambridge Entpr Ltd Biomarkers
EP2521916A4 (en) 2010-01-04 2013-12-04 Lineagen Inc BIOMARKER FOR THE LUNGS FUNCTION
US8643274B2 (en) 2010-01-26 2014-02-04 Scinopharm Taiwan, Ltd. Methods for Chemical Equivalence in characterizing of complex molecules
JP5337096B2 (ja) 2010-04-28 2013-11-06 株式会社日立製作所 動脈硬化の評価法
GB201008340D0 (en) 2010-05-19 2010-07-07 Cambridge Entpr Ltd Biomarkers
CN103299192B (zh) 2010-09-21 2016-05-11 普罗蒂阿米克斯国际有限公司 与糖尿病前期、糖尿病以及糖尿病相关病症相关的生物标记
GB201018056D0 (en) 2010-10-26 2010-12-08 Cambridge Entpr Ltd Biomarkers
EP2447980B1 (en) * 2010-11-02 2019-05-22 Thermo Fisher Scientific (Bremen) GmbH Method of generating a mass spectrum having improved resolving power
ES2530175T3 (es) 2011-02-17 2015-02-26 Nestec S.A. Ensayos para la detección de autoanticuerpos contra fármacos anti-TNF
WO2012149299A2 (en) 2011-04-29 2012-11-01 Celgene Corporaiton Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
CA2833212C (en) * 2011-05-12 2020-06-09 Genentech, Inc. Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides
CA2840687C (en) * 2011-07-01 2020-04-28 Dana-Farber Cancer Institute, Inc. Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma
EP2732423A4 (en) * 2011-07-13 2014-11-26 Multiple Myeloma Res Foundation Inc METHOD FOR DETECTING AND DISTRIBUTING DATA
GB2495113A (en) * 2011-09-29 2013-04-03 Bioinvent Int Ab Anti-ICAM-1 antibody for treating multiple-myeloma-related disorders
CA2848520C (en) * 2011-09-29 2019-11-26 Seattle Genetics, Inc. Intact mass determination of protein conjugated agent compounds
EP2783214A2 (en) 2011-11-23 2014-10-01 The Board of Regents of The University of Texas System Proteomic identification of antibodies
AU2012359020B2 (en) 2011-12-19 2017-04-13 The Washington University Methods for diagnosing Alzheimer's disease
GB201203938D0 (en) * 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
WO2013166594A1 (en) 2012-05-10 2013-11-14 Zymeworks Inc. Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain
WO2013181576A2 (en) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods of evaluating and making biologics
WO2013185180A1 (en) 2012-06-14 2013-12-19 Central Adelaide Local Health Network Inc. Method for identifying a diagnostic biomarker for an antibody of interest
WO2013191908A1 (en) * 2012-06-20 2013-12-27 The University Of North Carolina At Chapel Hill Integrated sample processing for electrospray ionization devices
EP2893353A2 (en) 2012-09-10 2015-07-15 Koninklijke Philips N.V. Analysis of saliva proteome for biomarkers of gingivitis and periodontitis using ft-icr-ms/ms
WO2014078374A2 (en) 2012-11-13 2014-05-22 Presage Biosciences, Inc. Methods for multiplexed drug evaluation
US20140186332A1 (en) 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
WO2014109927A1 (en) 2013-01-11 2014-07-17 The Regents Of The University Of Michigan Synthesis and isolation of dendrimer based imaging systems
CN103217489B (zh) 2013-01-15 2016-03-09 珠海市丽珠单抗生物技术有限公司 一种测定蛋白纯化工艺过程中样品的糖基化和末端修饰情况的方法
CN103217499B (zh) 2013-01-15 2015-12-02 珠海市丽珠单抗生物技术有限公司 一种测定免疫球蛋白电荷异构体的糖基化和末端修饰情况的方法
WO2014121031A1 (en) 2013-01-31 2014-08-07 Excelimmune, Inc. Characterization of antibody mixtures by mass spectrometry
CA2902841A1 (en) 2013-03-13 2014-10-02 Creatics Llc Methods and compositions for detecting pancreatic cancer
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
WO2014150170A1 (en) 2013-03-15 2014-09-25 Mayo Foundation For Medical Education And Research Identification and monitoring of monoclonal immunoglobulins by molecular mass
EP3043806A4 (en) 2013-09-11 2017-05-17 University Of Southern California A composition of stem cells having highly expressed fas ligand
GB201316744D0 (en) 2013-09-20 2013-11-06 Genovis Ab Method
CN103792315B (zh) 2014-01-23 2015-07-08 中国计量科学研究院 一种人血清蛋白无机质谱联用技术的定量方法
WO2015120036A1 (en) 2014-02-04 2015-08-13 University Of Virginia Patent Foundation Compositions and methods for analysis of protein sequences and post-translational modifications
WO2015131169A2 (en) 2014-02-28 2015-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Personalized myeloma detection
US9618524B2 (en) 2014-03-26 2017-04-11 Plaxgen Inc. Method, composition, isolation and identification of a plaque particle and related biomarker
US10267806B2 (en) 2014-04-04 2019-04-23 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
EP2975401B1 (en) 2014-07-18 2019-12-25 Hexal AG Improved method of mapping glycans of glycoproteins in serum samples
WO2016018978A1 (en) 2014-07-29 2016-02-04 Mayo Foundation For Medical Education And Research Quantifying monoclonal antibody therapeutics by lc-ms/ms
WO2016134365A1 (en) 2015-02-20 2016-08-25 The Johns Hopkins University Biomarkers of myocardial injury
KR102000862B1 (ko) 2015-03-09 2019-07-16 가부시키가이샤 시마즈세이사쿠쇼 질량 분석을 사용한 모노클로날 항체의 검출 방법
CA2980189A1 (en) 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
US12404552B2 (en) 2015-07-17 2025-09-02 Allele Biotechnology & Pharmaceuticals, Inc. Methods of selecting antibodies and antibody fragments
JP6666916B2 (ja) 2015-08-06 2020-03-18 積水メディカル株式会社 腎疾患の検査方法
JP6968058B2 (ja) 2015-09-24 2021-11-17 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 質量分析法による免疫グロブリン遊離軽鎖の同定
US12006530B2 (en) 2016-02-04 2024-06-11 Genovis Ab Streptococcal proteases
WO2017144903A1 (en) 2016-02-25 2017-08-31 The Binding Site Group Limited Antibodies
WO2017180735A1 (en) 2016-04-12 2017-10-19 Biocrypton Inc. Compositions and methods for screening, monitoring and treating gastrointestinal diseases
US10309968B2 (en) 2016-05-18 2019-06-04 Bioinformatics Solutions Inc. Methods and systems for assembly of protein sequences
US11067583B2 (en) 2016-05-25 2021-07-20 University Of Maryland, Baltimore Methods of making active antibodies from biological fluids
CN109863395B (zh) 2016-09-07 2023-05-23 梅约医学教育与研究基金会 分子量法鉴定和监测裂解免疫球蛋白
WO2019055632A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN CHAINS J
WO2019055631A1 (en) 2017-09-13 2019-03-21 Mayo Foundation For Medical Education And Research IDENTIFICATION AND MONITORING OF ACID HYDROLYSIS PRODUCTS OF IMMUNOGLOBULIN HEAVY CHAINS
EP3681528B1 (en) 2017-09-13 2025-07-23 Mayo Foundation for Medical Education and Research Identification and monitoring of apoptosis inhibitor of macrophage

Also Published As

Publication number Publication date
DK3729958T3 (da) 2023-08-07
US12546782B2 (en) 2026-02-10
PT3387898T (pt) 2020-06-17
US20160041184A1 (en) 2016-02-11
EP3729958A1 (en) 2020-10-28
ES2802805T3 (es) 2021-01-21
EP3387898A1 (en) 2018-10-17
WO2014150170A1 (en) 2014-09-25
EP2966985A1 (en) 2016-01-20
EP2966985B1 (en) 2018-09-19
DK3387898T3 (da) 2020-08-03
EP2966985A4 (en) 2017-03-15
ES2702183T3 (es) 2019-02-27
EP3729958B1 (en) 2023-05-03
EP3387898B1 (en) 2020-05-13
ES2951899T3 (es) 2023-10-25

Similar Documents

Publication Publication Date Title
PL3387898T3 (pl) Identyfikacja i monitorowanie immunoglobulin monoklonalnych na podstawie masy cząsteczkowej
IL290412B (en) Novel cd47 monoclonal antibodies and uses thereof
IL258121A (en) Anti-pro/latent-myostatin antibodies and uses thereof
DK3089994T3 (da) Fabs-in-tandem-immunglobulin og anvendelser deraf
MA40889A (fr) Immunoglobulines héréro-dimériques reciblant des lymphocytes
DK2825559T3 (da) Letisolerbare bispecifikke antistoffer med nativt immunoglobulinformat
PL2948477T3 (pl) Konstrukty przeciwciała dla cdh19 i cd3
PT3071595T (pt) Anticorpo anti calicreína-2 humanizado
PT3016681T (pt) Anticorpos humanizados ou quiméricos cd3
HUE040234T2 (hu) Humanizált anti-CD134 (OX40) antitestek és felhasználásaik
PL3712174T3 (pl) Przeciwciała i fragmenty anty-vista
DK3336106T3 (da) Anti-fcrh5-antistoffer
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
DK3587448T3 (da) Heterodimere proteiner
ME03489B (me) Molekuli antitijela na tim-3 i njihove upotrebe
BR112014024769A2 (pt) anticorpo humanizado tau
EP3070168C0 (en) ANTIGEN-BINDING MOLECULE CONTAINING MODIFIED ANTIBODY VARIABLE REGION
PL3971212T3 (pl) Białka wiążące antygen receptora onkostatyny m
DK3068800T3 (da) FcRn-specifikke antistoffer
IL240753B (en) Methods for purifying antibodies
DK3052522T3 (da) Anti-sox 10 antistofsystemer og -fremgangsmåder
DK3047163T3 (da) Lukkeelement
DK3094353T3 (da) Rsv-specifikke antistoffer og funktionelle dele deraf
HUE059507T2 (hu) BAFF-ra és B7RP1-re specifikus fehérjék és alkalmazásuk
DK3065774T3 (da) Anti-CCL17-antistoffer